HSCS Stock Analysis: Buy, Sell, or Hold?
HSCS - HeartSciences Inc. Common Stock
$1.77
-0.07 (-3.80%)
▼
5d:
-1.67%
30d:
-8.29%
90d:
-30.59%
HOLD
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Jul 23, 2026
29d
Get Alerted When HSCS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: HSCS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: HSCS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: HSCS is currently trading at $1.77, which is considered oversold relative to its 30-day fair value range of $1.79 to $1.98.
Technical Outlook: Technically, HSCS is in a strong downtrend. Immediate support is located at $1.63, while resistance sits at $2.24. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: HSCS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $10.00 (+465.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, HSCS is in a strong downtrend. Immediate support is located at $1.63, while resistance sits at $2.24. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: HSCS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $10.00 (+465.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.79 -
$1.98
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.8%)
- BULLISH: Trading 465.0% below Wall St target ($10.00)
Trading Range Analysis
30-Day Trading Range
$1.79 -
$1.98
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.63
Resistance Level
$2.24
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.63
Wall Street Target
$10.00
(+465.0%)
Revenue Growth (YoY)
653.8%
Share & Embed Analysis
Last updated: June 23, 2026 4:09 AM ET
Data refreshes hourly during market hours. Next update: 5:09 AM
Data refreshes hourly during market hours. Next update: 5:09 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HSCS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 52 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 59 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 60 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 63 BUY |
